Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-HZ in Healthy Adult Volunteers
Clinical trial NCT04210752 · COMPLETED
Trial details
- NCT number
- NCT04210752
- Sponsor
- EyeGene Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-24
- Primary completion
- 2020-12-03
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.